IN2014DN09053A - - Google Patents

Download PDF

Info

Publication number
IN2014DN09053A
IN2014DN09053A IN9053DEN2014A IN2014DN09053A IN 2014DN09053 A IN2014DN09053 A IN 2014DN09053A IN 9053DEN2014 A IN9053DEN2014 A IN 9053DEN2014A IN 2014DN09053 A IN2014DN09053 A IN 2014DN09053A
Authority
IN
India
Prior art keywords
tetrahydrolactoylpterin
lactoylpterin
sepiapterin
reaction formula
good yield
Prior art date
Application number
Other languages
English (en)
Inventor
Hiroshi Yoshino
Taichi Komoda
Yuichi Shiro
Shunichi Murata
Shizuaki Murata
Yasuhiro Kuroda
Original Assignee
Shiratori Pharm
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shiratori Pharm filed Critical Shiratori Pharm
Publication of IN2014DN09053A publication Critical patent/IN2014DN09053A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D475/00Heterocyclic compounds containing pteridine ring systems
    • C07D475/02Heterocyclic compounds containing pteridine ring systems with an oxygen atom directly attached in position 4
    • C07D475/04Heterocyclic compounds containing pteridine ring systems with an oxygen atom directly attached in position 4 with a nitrogen atom directly attached in position 2
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Peptides Or Proteins (AREA)
IN9053DEN2014 2012-05-07 2013-05-07 IN2014DN09053A (cg-RX-API-DMAC10.html)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2012105758 2012-05-07
JP2012247255 2012-11-09
PCT/JP2013/062817 WO2013168693A1 (ja) 2012-05-07 2013-05-07 セピアプテリン及びテトラヒドロラクトイルプテリンの製造法

Publications (1)

Publication Number Publication Date
IN2014DN09053A true IN2014DN09053A (cg-RX-API-DMAC10.html) 2015-05-22

Family

ID=49550728

Family Applications (1)

Application Number Title Priority Date Filing Date
IN9053DEN2014 IN2014DN09053A (cg-RX-API-DMAC10.html) 2012-05-07 2013-05-07

Country Status (8)

Country Link
US (1) US9181254B2 (cg-RX-API-DMAC10.html)
EP (1) EP2848619B1 (cg-RX-API-DMAC10.html)
JP (1) JP6084967B2 (cg-RX-API-DMAC10.html)
CN (1) CN104736539B (cg-RX-API-DMAC10.html)
ES (1) ES2681345T3 (cg-RX-API-DMAC10.html)
FR (1) FR25C1044I1 (cg-RX-API-DMAC10.html)
IN (1) IN2014DN09053A (cg-RX-API-DMAC10.html)
WO (1) WO2013168693A1 (cg-RX-API-DMAC10.html)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2715992C (en) * 2008-02-21 2016-11-08 Teikoku Seiyaku Co., Ltd. Apparatus and method for simulatively measuring the environment of a wound dressing on skin
JP5066756B2 (ja) 2010-04-22 2012-11-07 学校法人日本大学 脳機能障害予防・改善用の薬剤及び飲食物
JP6809781B2 (ja) * 2015-11-18 2021-01-06 白鳥製薬株式会社 プテリン誘導体又はその塩
IL266955B2 (en) * 2016-11-29 2023-09-01 Ptc Therapeutics Mp Inc Polymorphs of spiafatrin and its salts
WO2018102314A1 (en) 2016-11-29 2018-06-07 Censa Pharmaceuticals Inc. Polymorphic form of sepiapterin
EP3675863A4 (en) 2017-09-01 2021-01-27 PTC Therapeutics MP, Inc. PHARMACEUTICAL COMPOSITION CONSISTING OF SEPIAPTERIN AND ITS USES
CA3102070A1 (en) * 2018-05-30 2019-12-05 Ptc Therapeutics Mp, Inc. Pharmaceutically acceptable salts of sepiapterin
WO2019232130A1 (en) 2018-05-30 2019-12-05 Censa Pharmaceuticals Inc. Methods for increasing sepiapterin plasma exposure
JP7547215B2 (ja) 2018-05-30 2024-09-09 ピーティーシー セラピューティクス エムピー,インコーポレイテッド テトラヒドロビオプテリン血漿曝露を増加させるための組成物及び方法
CN117088883B (zh) * 2022-12-05 2025-10-21 哈尔滨工业大学(深圳) 一种以Pd/Al2O3为催化剂连续加氢制备四氢叶酸的方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1262347A (en) 1985-01-28 1989-10-17 Suntory Limited Preparation process of (6r)-tetrahydro-l-biopterin
JPS61172877A (ja) 1985-01-28 1986-08-04 Shiratori Seiyaku Kk (6r)−テトラヒドロ−l−バイオプテリンの製造方法
JP5184783B2 (ja) 2003-11-17 2013-04-17 バイオマリン ファーマシューティカル インコーポレイテッド テトラヒドロビオプテリン、及びテトラヒドロビオプテリン類似体の製造方法
JP2011011976A (ja) 2007-10-10 2011-01-20 Shiratori Pharmaceutical Co Ltd プテリジン化合物及びl−ビオプテリンの製造方法
JP5066756B2 (ja) 2010-04-22 2012-11-07 学校法人日本大学 脳機能障害予防・改善用の薬剤及び飲食物

Also Published As

Publication number Publication date
CN104736539B (zh) 2017-09-01
EP2848619B1 (en) 2018-07-11
JPWO2013168693A1 (ja) 2016-01-07
WO2013168693A1 (ja) 2013-11-14
US20150119574A1 (en) 2015-04-30
JP6084967B2 (ja) 2017-02-22
US9181254B2 (en) 2015-11-10
EP2848619A1 (en) 2015-03-18
ES2681345T3 (es) 2018-09-12
FR25C1044I1 (fr) 2026-01-02
EP2848619A4 (en) 2015-11-04
CN104736539A (zh) 2015-06-24

Similar Documents

Publication Publication Date Title
IN2014DN09053A (cg-RX-API-DMAC10.html)
MX2015002616A (es) Sintesis de bis(fluorosulfonil)imida.
MX353553B (es) Metodo para producir derivados de 4,4-difluoro-3,4-dihidroisoquino lina.
AP3450A (en) Process for the synthesis of methanol
MY192466A (en) Processes for the preparation of an apoptosis-inducing agent
MX2015007645A (es) Cyanobacterium sp. para produccion de compuestos.
MX370649B (es) Proceso para la preparacion de teneligliptina.
WO2015008218A3 (en) Process for the preparation of suvorexant and intermediates useful in the synthesis of suvorexant
IN2015DN01061A (cg-RX-API-DMAC10.html)
PH12015501807B1 (en) Vortioxetine manufacturing process
MX2013013463A (es) Nuevo procedimiento para la síntesis de rifaximina y una nueva forma pseudocristalina de rifaximina obtenida con el mismo.
MX362689B (es) Procedimiento de preparacion de derivados de acido 3,5-bis(fluoroalquil)pirazol-4-carboxilico y 3,5-bis(fluoroalquil) pirazoles.
MX2016005496A (es) Sintesis de fluorotrifluorometilsulfonil-imida.
MX2015013589A (es) Proceso e intermediario para la preparacion de pregabalina.
UA119435C2 (uk) Об'єднаний спосіб одержання метанолу і метилацетату
IN2014DN06192A (cg-RX-API-DMAC10.html)
PH12015502121A1 (en) Novel processes for producing sovaprevir
NZ720106A (en) A process for the preparation of regadenoson
MX343856B (es) Procedimiento para la preparación de derivados 1-h-pirrolidin-2,4-diona.
MX2014003936A (es) Procedimiento para preparar ditiina-tetracarboximidas.
EP2714766A4 (en) METHOD FOR PRODUCING POLYMERS THROUGH COUPLING REACTIONS
MX2013002395A (es) Procedimiento de preparacion de ditiin-tetracarboximidas.
MY156773A (en) Preparing ether carboxylates
MX2015017747A (es) Proceso para producir 2-fenil-1, 3-benzoxazoles.
PH12014501760A1 (en) Method for stereoselective synthesis of 1,4-protected 9-hydroxy-5-oxo-1,4-diaza-spiro[5.5]undecanes